Latest Resonance Network News
Dec 20, 2016
BTC Network rebrands, acquires Novex Clinical Research Clinical trials technology company Nimblify, Inc. , a Forte Research Systems company, announced today that its comparative analytics tool for clinical research sites, Research Resonance Network (RRN) has officially been renamed to Nimblify Site Benchmarks . This name change reflects the true benefit of the product – benchmarking your site’s operational metrics against other similar organizations. Site Benchmarks will remain free of charge for all sites in the industry and provide the same invaluable information to help sites identify areas of improvement and ultimately drive change by turning insight into action. With more than 46,900 protocols included in its benchmarks data to date, Site Benchmarks has become a powerful tool to empower sites. “Since RRN has evolved and grown, we’ve decided that a rebrand was necessary to communicate the true value to sites – the unique ability to compare your performance to your peers,” said Shree Kalluri, Founder & CEO of Nimblify. “We feel that the new name is more representative of one of the few tools in the industry that uses site-driven metrics. It puts the power in the sites’ hands to drive discussions on performance and use the data to improve,” added Kalluri. The tool provides a mechanism for sites to contribute a standardized set of operational metrics and compare their performance to an anonymous, aggregated group of peer organizations. Site Benchmarks connects to the site’s clinical trial management system (CTMS) to pull operational data, including cycle times, that measure the time between milestones in study activation, enrollment metrics and more. There is also an open application programming interface (API) available that allows technology vendors to integrate their CTMS with Site Benchmarks, as well as a standard spreadsheet template through which data can be uploaded into Site Benchmarks. The dashboards included help sites visualize performance, identify trends, drive process improvements and monitor changes over time. Though the platform was launched in 2013, its origins date back to seven years prior when 20 of the nation’s top research centers began collaborative efforts to develop data definitions and identify key metrics to track from the site perspective. Thus, a standard set of site-based operational metrics were created and are used in the tool today to provide a holistic view of performance. In 2014, RRN won the Clinical Informatics News Best Practices Award for Clinical Data Intelligence . Earlier this year, the tool was moved from Forte to the company’s wholly owned subsidiary, Nimblify. For more information, or to join Site Benchmarks, visit http://nimblify.com/benchmarks/ . About Nimblify Nimblify, Inc. is a clinical trials technology company dedicated to improving trial outcomes by connecting stakeholders in clinical research in innovative ways. Nimblify created Participant Payments, an ever-evolving patient-centric payment system, and hosts Site Benchmarks, a free award-winning metrics and comparative analytics tool for sites. Nimblify also collaboratively and continuously develops Research Insights, a cloud-based analytics platform with actionable information, and hosts the Protocol Calendar Exchange, a library of standardized schedule of events that can be downloaded by sites into their CTMS. Spun out of Forte Research Systems in August 2015, Nimblify is a privately held company and is headquartered in Madison, Wisconsin. For the original version on PRWeb visit: http://www.prweb.com/releases/2016/12/prweb13938720.htm
Resonance Network Frequently Asked Questions (FAQ)
When was Resonance Network founded?
Resonance Network was founded in 1999.
Where is Resonance Network's headquarters?
Resonance Network's headquarters is located at Atlanta.
What is Resonance Network's latest funding round?
Resonance Network's latest funding round is Unattributed VC.
Who are the investors of Resonance Network?
Investors of Resonance Network include Fuqua Ventures.